老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ATAI Life Sciences B.V.*

1.37
+0.02451.81%
成交量：28.36萬
成交額：39.04萬
市值：2.67億
市盈率：-1.47
高：1.40
開：1.36
低：1.35
收：1.35
資料載入中...
總覽公司新聞公告
2021/06/15

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/11

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/10

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/08

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/08

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/04

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/27

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/24

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/05/24

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/05/11

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/20

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/20

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/04/28

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/18

超過5%披露

Statement of acquisition of beneficial ownership by individuals
更多